Correlation Between Innate Pharma and Solocal Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Solocal Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Solocal Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Solocal Group SA, you can compare the effects of market volatilities on Innate Pharma and Solocal Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Solocal Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Solocal Group.

Diversification Opportunities for Innate Pharma and Solocal Group

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Innate and Solocal is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Solocal Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solocal Group SA and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Solocal Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solocal Group SA has no effect on the direction of Innate Pharma i.e., Innate Pharma and Solocal Group go up and down completely randomly.

Pair Corralation between Innate Pharma and Solocal Group

Assuming the 90 days trading horizon Innate Pharma is expected to under-perform the Solocal Group. But the stock apears to be less risky and, when comparing its historical volatility, Innate Pharma is 1.46 times less risky than Solocal Group. The stock trades about -0.14 of its potential returns per unit of risk. The Solocal Group SA is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  230.00  in Solocal Group SA on August 26, 2024 and sell it today you would earn a total of  59.00  from holding Solocal Group SA or generate 25.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Innate Pharma  vs.  Solocal Group SA

 Performance 
       Timeline  
Innate Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innate Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Solocal Group SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Solocal Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Solocal Group is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Innate Pharma and Solocal Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innate Pharma and Solocal Group

The main advantage of trading using opposite Innate Pharma and Solocal Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Solocal Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solocal Group will offset losses from the drop in Solocal Group's long position.
The idea behind Innate Pharma and Solocal Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories